Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Cytokinetics, Inc.. United States. Announced Date 19/05/2009. Closed Date 21/05/2009. Deal value: $14m. Registered direct offering of common stock. Industry: Cytokinetics, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of muscle biology-driven treatments for diseases.